autoimmune disease

Can Bristol-Myers Win the Autoimmune Market with Padlock Acquisition?
Bidness, ETC
Mon, 03/28/16 - 08:46 am
Bristol-Myers Squibb
Padlock Therapeutics
autoimmune disease
M&A
On a crash course with Celgene? Biogen inks a $544M autoimmune drug deal
Fierce Biotech
Wed, 09/9/15 - 08:12 am
Celgene
Biogen
autoimmune disease
MT-1303
Mitsubishi Tanabe Pharma
AbbVie could end up sidestepping lost sales tied to an expiring patent on Humira in 2017
Motley Fool
Sun, 08/23/15 - 11:40 am
AbbVie
Humira
patents
Imbruvica
autoimmune disease
Autoimmune Drugs to Drive Big Pharma Higher in Coming Years
24/7 Wall St
Mon, 06/8/15 - 09:58 pm
autoimmune disease
AbbVie
JNJ
Eli Lilly
Merck
Bristol-Myers Squibb
Pfizer
Astellas wagers $760M to launch an autoimmune biotech in Cambridge, MA
Fierce Biotech
Wed, 06/3/15 - 11:12 am
Astellas
autoimmune disease
Kanyos Bio
Anokion
Does Celgene Have Another Blockbuster on the Way?
Investopedia
Thu, 03/26/15 - 09:45 pm
Celgene
GED-0301
autoimmune disease
Crohn's Disease
Bristol-Myers buys rights to Novo Nordisk immune system project
Yahoo/Reuters
Tue, 03/24/15 - 10:30 am
Novo Nordisk
Bristol-Myers Squibb
autoimmune disease
Lilly inks a $690M deal to get its hands on an autoimmune drug
Fierce Biotech
Fri, 03/20/15 - 08:18 am
Eli Lilly
Korea
Hanmi Pharmaceutical
autoimmune disease
Sanofi beefs up its autoimmune pipeline with a biotech deal
Fierce Biotech
Wed, 02/18/15 - 10:58 am
Sanofi
Lead Pharma
autoimmune disease
If Pfizer's Right, Hospira Biosimilar Gold Rush Begins This Week
Forbes
Mon, 02/16/15 - 11:55 am
Pfizer
Hospira
M&A
biosimilars
Inflectra
Europe
autoimmune disease
J&J buys bowel drug license option from Isis Pharma for $835 mln
Yahoo/Reuters
Mon, 01/5/15 - 09:07 am
JNJ
Isis Pharmaceuticals
autoimmune disease
inflammatory bowel disease
Virobay tees up a $50M IPO to get a trio of candidates into Phase II
Fierce Biotech
Thu, 09/11/14 - 10:46 am
Virobay
IPOs
autoimmune disease
painkillers
Virobay banks $8M to accelerate its treatments for pain, autoimmunity
Fierce Biotech
Thu, 07/17/14 - 10:05 am
Virobay
autoimmune disease
neuropathic pain
VBY-036
VBY-376
AstraZeneca reports mavrilimumab, sifalimumab studies met primary endpoints
The Fly on the Wall
Mon, 05/12/14 - 11:51 am
mavrilimumab
sifalimumab
AstraZeneca
MedImmune
lupus
autoimmune disease
rheumatoid arthritis
Idera: A Compelling Biotech Pick For March
Seeking Alpha
Fri, 03/7/14 - 12:12 pm
Idera Pharmaceuticals
psoriasis
autoimmune disease
J&J Innovation launches a discovery pact with fledgling upstart Scholar Rock
Fierce Biotech
Wed, 01/8/14 - 09:39 am
Scholar Rock
JNJ Innovation
JNJ
autoimmune disease
Idera Pharmaceuticals Presents a Promising Opportunity
Wall St Cheat Sheet
Thu, 12/26/13 - 02:45 pm
Idera Pharmaceuticals
autoimmune disease
IMO-8400
IMO-9200
B cell lymphoma
Pfizer nabs autoimmune disease drug rights for $25M upfront
Fierce Biotech
Mon, 09/30/13 - 11:50 am
Pfizer
autoimmune disease
GL-2045
Gliknik
Questcor Surges After Acquiring Rights to Novartis Drug
Bloomberg
Tue, 06/11/13 - 10:41 am
Questcor
Novartis
Synacthen
autoimmune disease
ulcerative colitis
The Arena Pipeline Potential
Seeking Alpha
Fri, 05/31/13 - 12:59 pm
Arena Pharmaceuticals
Belviq
Vivus
APD811
pulmonary hypertension
Termanogrel
deep vein thrombosis
APD334
autoimmune disease

Pages